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Abstract
Background: CTCF and BORIS (CTCFL), two paralogous mammalian proteins sharing nearly identical DNA binding
domains, are thought to function in a mutually exclusive manner in DNA binding and transcriptional regulation.
Results: Here we show that these two proteins co-occupy a specific subset of regulatory elements consisting of
clustered CTCF binding motifs (termed 2xCTSes). BORIS occupancy at 2xCTSes is largely invariant in BORIS-positive
cancer cells, with the genomic pattern recapitulating the germline-specific BORIS binding to chromatin. In contrast
to the single-motif CTCF target sites (1xCTSes), the 2xCTS elements are preferentially found at active promoters
and enhancers, both in cancer and germ cells. 2xCTSes are also enriched in genomic regions that escape histone
to protamine replacement in human and mouse sperm. Depletion of the BORIS gene leads to altered transcription
of a large number of genes and the differentiation of K562 cells, while the ectopic expression of this CTCF paralog
leads to specific changes in transcription in MCF7 cells.
Conclusions: We discover two functionally and structurally different classes of CTCF binding regions, 2xCTSes and
1xCTSes, revealed by their predisposition to bind BORIS. We propose that 2xCTSes play key roles in the
transcriptional program of cancer and germ cells.
Background
CTCF, a highly conserved DNA binding protein, serves
as a global organizer of chromatin architecture [1]. It is
involved in the regulation of transcriptional activation
and repression, gene imprinting, control of cell prolifer-
ation and apoptosis, chromatin domain insulation, X-
chromosome inactivation, prevention of oligonucleotide
repeat expansion, and other chromatin resident pro-
cesses [2–11]. The multifunctionality of CTCF is based
on its ability to bind a wide range of diverse DNA
sequences as well as to interact with cofactor proteins
through the combinatorial use of 11 C2H2 zinc fingers
(ZFs) [12–15]. With the advance of next-generation
sequencing techniques, CTCF binding sites have been
identified across fly, mouse, and human genomes
[14, 16, 17]. The genome-wide studies helped defined the
DNA binding specificity of CTCF, known as CTCF target
sites (CTSes) [1, 13, 18]. CTSes tend to be conserved in
evolution and occupancy is largely invariant across differ-
ent cell types. Reflecting the multitude of CTCF functions,
CTSes were found to be associated with the genomic
regions engaged in long-range chromatin interactions,
including enhancers [19], promoters [14], insulators [20]
and boundary elements [8]. The capacity of CTCF–DNA
complexes to form loops via protein dimerization as
originally described for the H19-IFG2 imprinted locus
[21] has been confirmed genome-wide by three-
dimensional approaches, solidifying the key role of
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CTCF in the organization of chromatin architecture
[7, 22]. For example, CTCF-mediated chromatin loops
were shown to connect enhancers with promoters [19], to
insulate promoters from enhancers [23], to mediate im-
printing of mammalian genes [24], to control V(D)J
recombination [25], and to organize the major histocom-
patibility complex (MHC) class II genes [26]. It remains
obscure, however, how the DNA sequences of given
CTSes are related to the specific CTCF functions at these
sites.
CTCF gene duplication during early evolution of amni-
otes gave rise to Brother Of the Regulator of Imprinting
Sites (BORIS) [27, 28]. CTCF and BORIS encode proteins
that share an almost identical DNA binding domain rec-
ognizing the same DNA sequences in vivo and in vitro
[29–32]. It has long been thought that CTCF and BORIS
possess distinct functions and act in a mutually exclusive
manner. Indeed, while CTCF is ubiquitously expressed,
BORIS expression is strictly restricted to germ cells in
normal development [27]. However, BORIS is aberrantly
expressed in a wide range of cancers, and its function in
that context has not been characterized [31, 33–36]. To
date, established BORIS functions are limited to the tran-
scriptional activation or repression of some germline and
cancer-related genes [29, 30, 32]. Due to the completely
distinct amino and carboxyl termini of CTCF and BORIS
proteins, differences in biological functions between the
two factors were expected. This was supported by the
contrasting phenotypes of their germline knockouts as
well as by the inability of BORIS to complement CTCF
mutations [29, 30, 37]. The homozygous deletion of CTCF
in mice showed early embryonic lethality at the peri-
implantation stage [37]. In contrast, BORIS knockout
mice showed subfertility and multiple defects in sperm-
atogenesis, including a reduction in testis size and delayed
production of gametes [29, 30].
The fact that CTCF and BORIS share a virtually iden-
tical DNA binding domain and are co-expressed in at
least two environments, in germ and cancer cells [13],
raises the question of whether they bind competitively
or cooperatively at a given DNA sequence [13, 27, 38]. It
has been proposed that CTCF and BORIS compete for
DNA binding with the complete replacement of one
protein by the other at target sequences [27, 30]. This
model predicts disruption of CTCF function in cancer
cells or in germ cells. Given the important function of
CTCF as a genome-organizer, however, the above
model would also predict global disruption of genome
organization and consequently large-scale changes in
gene expression patterns. To address this problem, we
have developed and utilized a set of monoclonal and
polyclonal antibodies to map CTCF and BORIS binding
sites in both human and mouse genomes. We report
here, for the first time, CTCF and BORIS occupancy of
chromatin in germ cells and in several cancer cell types.
We found that BORIS, together with CTCF, occupies as
much as one-third of CTSes and “sidesteps” the
remaining two-thirds of CTSes regardless of the origin
of cancer cells. We demonstrate that the pattern of
BORIS occupancy in cancer cells expressing this pro-
tein largely recapitulates its binding in germ cells,
suggesting that the ability of a CTCF binding region to
be occupied by BORIS in vivo is encoded in the DNA
sequence and the site’s architecture. We further show
that CTCF and BORIS bound regions (CTCF&BORIS)
typically contain at least two proximal CTSes (2xCTS)
in germ and cancer cells. 2xCTS elements are preferen-
tially found at active promoters and enhancers, and are
associated with retained histones in human and mouse
sperm, in stark contrast to genomic regions harboring a
single CTS (1xCTS). Our results also establish the
functional significance of 2xCTSes in cell-specific gene
expression.
Results
BORIS selectively binds to a subset of CTCF binding
regions in cancer cells regardless of tissue origin
CTCF and BORIS share a conserved 11 ZF DNA bind-
ing domain (Fig. 1a) and, as a result, are identical in
DNA binding specificity in vitro [27, 32, 39]. In vitro
assays on single CTCF binding sites indicate that CTCF
and BORIS compete for DNA binding with the complete
replacement of one protein by the other at target se-
quences (Fig. 1b). It is unclear, though, whether the two
proteins would compete for binding to the same genomic
regions in vivo. To better understand the functional inter-
play between CTCF and BORIS in human cells, we per-
formed ChIP-seq in three cancer cell lines — K562
(chronic myelogenous leukemia line), Delta47 (multiple
myeloma line), and OVCAR8 (ovarian cancer line) — all
of which express comparable levels of CTCF and BORIS
proteins in the nucleus (Fig. S1a–c in Additional file 1).
For this purpose, we developed a large set of anti-CTCF
and anti-BORIS mouse monoclonal antibodies, thor-
oughly validated by immunoblotting, electrophoretic mo-
bility shift assay (EMSA), and ChIP-seq for both BORIS-
positive cancer cells and BORIS-negative normal human
dermal fibroblasts (NHDFs) (Fig. 1c–h; Fig. S1b-d in
Additional file 1). The patterns of BORIS and CTCF occu-
pancy were very similar among the three cancer cell lines
despite their distinct tissue origins (Fig. 1d–h; Fig. S1e, f in
Additional file 1). Contrary to the expectation of overlap-
ping CTCF and BORIS occupancy at all CTCF binding
regions, we observed that only a subset (~29–38 %) of
CTCF binding regions were also occupied by BORIS (des-
ignated here as CTCF&BORIS bound regions). Addition-
ally, in each tumor cell line we found a small number of
regions occupied by BORIS alone (BORIS-only bound
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regions), but the same regions were occupied by CTCF in
other cell lines (Fig. S1f–h in Additional file 1). Import-
antly, the majority of the CTSes were not bound by
BORIS in vivo (CTCF-only bound regions).
The model of simple competition between CTCF and
BORIS in vitro (Fig. 1b) would predict lower CTCF and
BORIS occupancy at CTCF&BORIS bound regions com-
pared with CTCF-only and BORIS-only bound regions.
Instead, the ChIP-seq peak intensity (tag density) for the
coinciding CTCF and BORIS peaks was significantly
higher compared with CTCF-only and BORIS-only
peaks, respectively (Fig. S2a in Additional file 2). ChIP-
Re-ChIP assay in K562 and Delta47 cells further con-
firmed that these CTCF&BORIS co-occupied regions
were simultaneously bound by both proteins (Fig. 1i; Fig.
S2b in Additional file 2), while CTCF-only and BORIS-
only bound regions lacked the co-occupancy (Fig. S2b in
Additional file 2). Taken together, the above evidence
suggests that CTCF bound regions detected by the ChIP-
seq approach are not homogeneous and can be subdivided
into at least two groups based on their potential to be also
occupied by BORIS.
The genomic regions co-occupied by CTCF and BORIS
proteins contain clustered CTCF binding sites
In order to determine whether DNA sequences per se
were responsible for the selective BORIS co-localization
with CTCF, we performed EMSA with three classes of
sequences: CTCF&BORIS, CTCF-only and BORIS-only
bound regions. We observed that full-length CTCF and
BORIS proteins bind the target sequences with similar af-
finity in vitro (Fig. S3 in Additional file 3). Unexpectedly,
EMSA with probes corresponding to CTCF&BORIS and
BORIS-only bound regions demonstrated a double shift
with the in vitro translated 11 ZF domain (Fig. S3a, c in
Additional file 3), indicating the presence of two adjacent
CTCF binding sites in keeping with the demonstration
that the same arrangement exists in the promoter of the
TSP50 (PRSS50) gene [32]. Furthermore, the testis-
specific TSP50 promoter is occupied by both CTCF and
BORIS proteins in all three human cancer cell lines,
thereby representing a bona fide CTCF&BORIS bound re-
gion with two conserved individual CTCF sites located 58
and 33 base pairs (bp) apart in the human and mouse
promoters, respectively (Fig. 2a). The contact guanine
residues, mapped for CTCF and BORIS binding at the
TSP50 promoter [32], coincided with two 20-bp CTCF
binding motifs. Moreover, the CTCF motif was found to
be represented at both CTCF and BORIS ChIP-seq peaks
(Fig. 2a; Fig. S4a in Additional file 4). Therefore, we exam-
ined other CTCF&BORIS bound regions for the hidden
presence of two CTCF binding sites utilizing the pre-
dictive power of the double CTCF motif feature de-
tected in the TSP50 promoter (Fig. 2a). Strikingly, 65 %
of CTCF&BORIS and 51 % of BORIS-only bound re-
gions consist of at least two closely spaced CTCF mo-
tifs, while CTCF-only bound regions generally (91 %)
have only one CTCF motif under the peak (Fig. 2b; Fig.
S4b–f in Additional file 4). To further validate this
observation, we screened several randomly picked gen-
omic loci representing either CTCF&BORIS or CTCF-
only bound regions by EMSA (Fig. 2c; Fig. S5a in
Additional file 5). All 12 CTCF&BORIS bound regions
produced the double shifts with the 11 ZF domain,
indicating the presence of two CTCF binding sites
(Fig. 2c; Fig. S5a in Additional file 5), while all 11
CTCF-only bound regions produced a single binding
shift pointing to a single CTCF binding site inside the
sequences (Fig. 2c; Fig. S5a in Additional file 5). One
could hypothesize that in the cases where a second
motif for a dual CTCF&BORIS bound region was not
identified, it is most likely still present but deviates
from the CTCF motif sequence. Indeed, five such
CTCF&BORIS bound regions produced double shifts
with the 11 ZF domain, confirming the presence of two
CTCF binding sites (Fig. S5a in Additional file 5).
(See figure on previous page.)
Fig. 1 Genomic profiling of CTCF and BORIS occupancy in human cancer cells. a Schematic representation of CTCF and BORIS zinc fingers (ZF) shows
the four essential amino acids involved in DNA recognition for each ZF. The amino acids of BORIS that differ from CTCF are highlighted in red. The
numbers between ZFs show linker length. b Electrophoretic mobility shift assay (EMSA) with increasing amount of full-length BORIS protein (left panel)
and unprogrammed TNT (right panel) on the background of a constant level of full-length CTCF protein. The fourth CTCF binding site out of seven
mapped in the H19-IGF2 imprinting control region (ICR) was used as the labeled probe. c, d Gene tracks show the distribution of CTCF (red) and BORIS
(blue) bound regions in the K562 cell line (c) and in cell lines K562, Delta47, OVCAR8, and normal human dermal fibroblasts (NHDFs) (d). The molecules
against which antibodies were directed and cell lines used in ChIP-seq are shown on the left. The number of tags per one million of mapped reads is
indicated. The gray frames and arrows show CTCF-only, CTCF&BORIS and BORIS-only bound regions. e–h Heatmaps depict CTCF (red) and BORIS (blue)
occupancy in NHDFs (e), K562 (f), OVCAR8 (g) and Delta47 (h) cells. e Heatmap shows the absence of BORIS occupancy at CTCF bound regions
mapped in BORIS-negative NHDFs. f The genome-wide overlapping of CTCF- and BORIS-bound regions mapped in K562 cells is shown on the
left side of the heatmap. The overlapping of CTCF and BORIS occupancy was done independently for each cell type. The tag density of CTCF
and BORIS ChIP-seq data was collected within a 10-kb window around the summit of CTCF (CTCF&BORIS and CTCF-only) and BORIS peaks
(BORIS-only). The collected data were subjected to k-means clustering using linear normalization based on similar tag density profiles. The
molecules against which antibodies were directed in ChIP-seq are listed on top of the heat map. i Heatmap shows the enrichment of ChIP-Re-ChIP
tag density at CTCF&BORIS-bound regions. ChIP-Re-ChIP occupancy (purple) is presented in comparison with CTCF (red) and BORIS (blue) ChIP-seq data
for Delta47 cells. The tag density was subjected to k-means ranked clustering with two clusters expected
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Therefore, we classified CTCF binding regions in the gen-
ome into clustered CTSes (2xCTSes) and single/individual
CTSes (1xCTSes). We further validated the 2xCTS model
by separating the two sub-sites of CTCF&BORIS bound
regions and demonstrating their independent binding to
the 11 ZF domain (Fig. S5b in Additional file 5).
The above data are consistent with the model of differ-
ential occupancy of CTCF bound regions by BORIS
(Fig. 2d). Namely, 1xCTSes and 2xCTSes could not be
discriminated at the resolution of ChIP-seq experiments
and were detected, therefore, as single CTCF binding sites
in both BORIS-positive (K562) and BORIS-negative
(NHDF) cells (Fig. 2d). In BORIS-positive cells, the
2xCTSes were preferentially occupied by both CTCF and
BORIS proteins (CTCF&BORIS), while 1xCTSes were
preferentially occupied only by CTCF (CTCF-only)
(Fig. 2d), thus revealing the two classes of CTCF binding
regions. To further test our model, we analyzed DNaseI
digital genomic footprinting and phastCons46 conserva-
tion score at 1xCTS and 2xCTS binding regions (Fig. 2d;
Fig. S6 in Additional file 6). Upon plotting DNaseI cleav-
age density and the conservation score across the two
classes of CTCF binding regions, we observed either single
or double footprints, respectively, with the corresponding
single or double conserved peaks, respectively (Fig. 2d;
Additional file 6). As 2xCTSes produced double footprints
in BORIS-negative (NHDF) cells as well as in BORIS-
positive cells, we could assume that the 2xCTSes were oc-
cupied by CTCF homodimers in the absence of BORIS
(Fig. 2d; Additional file 6).
Clustered CTCF binding sites facilitate CTCF and BORIS
interactions on DNA
The short linear distances between the clustered CTCF
motifs would likely support protein–protein interactions
between the bound partners at these regions in vivo. In-
deed, the inability to resolve two closely located CTCF
binding sites by ChIP-seq (Fig. 3a) directly supports CTCF
and BORIS interaction at 2xCTSes [40]. To test this
hypothesis, we performed co-immunoprecipitation experi-
ments and showed that CTCF and BORIS were associated
with each other in K562 cell nuclear extracts in the pres-
ence and absence of DNA (Fig. 3b). We also performed an
in situ proximity ligation assay (ISPLA) in BORIS-positive
ovarian cancer cells (OVCAR8) and human testis tis-
sues, confirming that CTCF and BORIS proteins are
co-localized in a chromatin context of both cancer and
germ cells where the two proteins are co-expressed
(Fig. 3c, d). We also observed increased co-occupancy
of DNA by CTCF with the wild-type probe (TP53 pro-
moter) compared with a probe of the same length but
with one of the two CTCF sites mutated (Fig. 3e). How-
ever, EMSA with increasing amounts of full-length
CTCF (Fig. 3e) showed not only increased occupancy of
both sites but also the appearance of a third, slower mi-
grating band that likely corresponds to a higher-order
CTCF–DNA complex. Furthermore, EMSAs with K562
nuclear extracts demonstrated that the DNA–protein
complexes were generally completely super-shifted with
both anti-CTCF and anti-BORIS antibodies (Fig. 3f; Fig.
S5c in Additional file 5), indicating preferential binding
(See figure on previous page.)
Fig. 2 CTCF&BORIS bound regions enclose at least two closely located CTCF binding sites. a Upper panel: gene track represents CTCF (red) and
BORIS (blue) binding at the TSP50 (PRSS50) promoter in K562 cells. Lower panel: the alignment of human and mouse sequences under the summit
of CTCF (red nucleotide) and BORIS (blue nucleotide) peaks mapped by ChIP-seq at the TSP50 promoter. Two CTCF core motifs (shown on the top
of the alignment) coincide with two CTCF binding sites (site1 and site2) previously identified by EMSA and methylation interference assay (MIA)
[32] in both mouse and human TSP50 promoters (labeled and underlined at the bottom of the alignment). Asterisks denote the contact guanines
mapped by MIA. The space between the two CTCF binding motifs in human and mouse TSP50 promoters varies from 33 bp to 58 bp (shown by
brackets). The phastCons conservation track shows the high conservation of two CTCF sites in the TSP50 promoter among 100 vertebrates. The
black arrow shows the beginning of TSP50 transcription. b The percentage of CTCF-only, CTCF&BORIS and BORIS-only peaks with two or more
CTCF motifs. The top 1000 CTCF-only, CTCF&BORIS and BORIS-only binding regions (invariant in three cancer cell lines) were selected for analysis.
The presence of a CTCF motif was calculated by FIMO (MEME suite) in the sequence extended 100 bp upstream and downstream of the summit
of either CTCF (CTCF-only and CTCF&BORIS) or BORIS (BORIS-only) peaks. Each CTCF motif occurrence has a p value < 0.0001. c Upper panel: EMSA
with five CTCF&BORIS (blue bracket) and four CTCF-only (red bracket) binding regions. The ~200-bp 32P-labeled probes were incubated with either
in vitro translated luciferase (−) or with the 11 ZF domain of CTCF (+). The slower (shown by arrow with two red dots) and faster (arrow with one
red dot) migrating shifted bands correspond to CTCF binding to two CTCF sites at once or to one CTCF site, respectively (double and single
occupancy). Lower panel: genome browser view of CTCF and BORIS occupancy in K562 and Delta47 cells at nine DNA sequences used in the
EMSA. The brackets show the connection between upper and lower panels. ChIP-seq data are shown in combination with ChIP-Re-ChIP-seq data
for K562 and Delta47 cells. ChIP-seq tracks are labeled with the molecule against which antibodies were directed and the cell line used. d First
row: individual examples of 1xCTS and 2xCTS, differentially occupied by CTCF and BORIS in BORIS-positive (K562) and BORIS-negative (NHDF) cells.
CTCF and BORIS ChIP-seq data are combined with digital genomic footprinting (DGF, ENCODE data) and phastCons46 conservation scores. The
core 20-bp CTCF motif is marked by a grey box. Second row: heatmaps show DNaseI cleavage density at thousands of 1xCTSes (single CTCF motif
on plus strand) and at hundreds of 2xCTSes (two CTCF motifs separated by a 30–40-bp linker, both on the minus strand). The tag density data
were collected within a 300-bp window around the first (left) 20-bp CTCF core motifs (0) under a single CTCF ChIP-seq peak. Third row: average
phastCons46 conservation score at 1xCTSes and 2xCTSes, the same genomic regions as in the second row. Fourth row: model of CTCF and BORIS
differential occupancy in NHDF and K562 cells. 1xCTSes are occupied by CTCF monomer in both BORIS-positive and BORIS-negative cells, while
2xCTSes are co-occupied by CTCF and BORIS in BORIS-positive cells or by CTCF homodimer in BORIS-negative cells
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Fig. 3 CTCF and BORIS interact at CTCF&BORIS bound regions. a ChIP-seq does not resolve the two closely spaced CTCF binding sites at CTCF&BORIS
bound regions: no enrichment of reads between two CTCF binding sites (black dots) in the middle panel compared with the right panel with two CTCF
binding regions resolved by ChIP-seq. b Western blot demonstrates co-immunoprecipitation of CTCF and BORIS complexes: K562 nuclear lysates were
immunoprecipitated with IgG, anti-CTCF and anti-BORIS antibodies. Precipitated complexes were probed with CTCF antibodies. The lysates were either
untreated (−) or treated (+) with ethidium bromide (EtBr) before co-immunoprecipitation. c, d In situ proximity ligation assay (ISPLA) shows the close prox-
imity between CTCF and BORIS proteins in BORIS-positive cells: ovarian cancer cells (OVCAR8) (c) and human testis tissue (d). e A 200-bp 32P-labeled probe
representing human TP53 promoter (2xCTS, the palindromic orientation of CTCF motifs shown by arrows) was incubated with increasing concentrations of
the 11 ZF domain of CTCF (11ZFs, left and middle panels) or Pichia recombinant full-length CTCF (FL CTCF, right panel). The 2xCTS was used in EMSA either
as wild type with two CTCF binding sites (grey boxes) or as the mutant type with one CTCF mutated site (red cross). The model of 11 ZFs and full-length
CTCF occupancies are shown by arrows and red dots (CTCF molecules). f A 200-bp 32P-labeled probe representing IRF2BP1 3’ untranslated region (UTR)
was incubated with nuclear extracts (n.e.) from either K562 or NHDF cells. All lanes contain the indicated nuclear extract, except the first lane for K562,
where only free probe is present. Nuclear extracts and probe were also incubated with either control mouse IgG (−), antibodies against CTCF or BORIS. The
red and blue arrows point to the super-shifted bands corresponding to CTCF–DNA and BORIS–DNA complexes, respectively. NHDF nuclear extract did not
produce a super-shift band with anti-BORIS antibodies. g Gene tracks show that exogenous BORIS expression in MCF7 cells (MCF7 + BORIS) recapitulates
endogenous BORIS occupancy in OVCAR8 cells. The name of the molecules against which antibodies were directed and the cell lines used in ChIP-seq are
shown in the tracks. h Heatmap of BORIS (blue) occupancy at 50,000 CTCF peaks invariantly mapped in both OVCAR8 and MCF7 + BORIS cells. The tag
density was subjected to k-means ranked clustering with two clusters expected. i ISPLA in BORIS-negative MCF7 cells stably transfected with either empty
vector (MCF7+EV) or BORIS (MCF7+BORIS). The specific positive ISPLA signal (red) is present only in MCF7 cells transfected with BORIS-expressing vector
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kinetics for heteromeric versus monomeric complexes.
Thus, based on several complementary approaches, we
can conclude that CTCF and BORIS interact directly at
2xCTSes.
The pattern of CTCF and BORIS occupancy across
different cancer cell lines raises the question of whether
CTCF and BORIS heterodimerization is preprogrammed
in the genome sequence by the 2xCTSes. To test this
idea, we induced ectopic BORIS expression in the
BORIS-negative breast cancer cell line MCF7 (Fig. 3g–i).
The pattern of exogenous BORIS occupancy completely
recapitulated the binding profile of endogenous BORIS
expression in OVCAR8 cells (Fig. 3g, h). Replacement of
CTCF homodimers by CTCF and BORIS heterodimers
was further confirmed by ISPLA where the positive
signal was detected only in nuclei of MCF7 cells with
exogenous BORIS expression (Fig. 3i). Thus, evidently,
CTCF and BORIS heterodimeric complexes are not only
common in cancer cells of different origins, but can be
formed upon induction of BORIS expression in BORIS-
negative cells.
Clustered CTCF binding sites are strongly enriched at
active promoters and enhancers in cancer cells
To investigate the functional relevance of clustered
CTCF binding sites, we analyzed chromatin organization
and the epigenetic landscape of cancer cells at these
regions. Comparison of the 2xCTSes (BORIS bound
regions: CTCF&BORIS and BORIS-only) identified in
K562 cells with the set of data generated by ENCODE
showed that most 2xCTSes were specifically associated
with active enhancers and promoters, in stark contrast
to 1xCTSes (CTCF-only bound regions) (Fig. 4a, b; Add-
itional file 7). About 87 % (15,305) of all active pro-
moters (17,656) in K562 cells, marked by enrichment of
the transcription initiating form of RNA polymerase II
and the active histone mark H3K4me3, had BORIS oc-
cupancy within 4 kb of transcription start sites (TSSs)
with the preferential co-occupancy by both CTCF and
BORIS proteins (Fig. S7a in Additional file 7). In con-
trast, only 4 % (666) of these promoters contained single
CTCF sites.
Similarly, 50 % (8714) of all active enhancers (17,798) in
K562 cells, as defined by H3 histone K27 acetylation and
p300 enrichment (histone acetyltransferase), coincided
with BORIS bound regions (Fig. S7a in Additional file 7).
Recently, a subclass of enhancers, called super enhancers,
was shown to orchestrate cell-specific transcription to de-
termine cell identity [41]. More than 76 % (563) of super
enhancers identified in K562 overlapped with BORIS
bound regions (Fig. S7b in Additional file 7).
Upon further analysis, we established that clustered
CTCF binding sites showed dramatically different chro-
matin features compared with 1xCTSes (Fig. 4a, b;
Additional file 7). Factors involved in active transcription,
such as RNA polymerase II (RNAPII), TAF1, YY1, TBP,
MYC, HMGN3, and PHF8 were highly (80–99.7 %)
enriched at CTCF&BORIS bound regions but depleted
(0–10 %) from CTCF-only bound regions (Fig. S7c–f in
Additional file 7). In contrast, the cohesin complex was
enriched at all CTCF bound regions, independent of
BORIS occupancy (Fig. 4b; Fig. S7c–f in Additional file 7).
Remarkably, RAD21 and SMC3 were depleted from
BORIS-only bound regions, suggesting that BORIS was
not able to recruit the cohesin complex without CTCF
(Fig. 4b; Fig. S7c, d, f in Additional file 7). Thus, BORIS-
only and CTCF&BORIS bound regions (2xCTSes) are
dramatically different from CTCF-only bound regions
(1xCTSes) with respect to their genomic distribution
(Fig. S7g in Additional file 7) and co-localization with
protein partners, levels, and landmarks of transcription,
and the epigenetic landscape of K562 cells (Fig. 4a, b;
Additional file 7).
To determine whether this difference stems from the
presence of BORIS at 2xCTSes or whether 2xCTSes are
themselves inherently functionally different from 1xCTSes,
we compared CTCF ChIP-seq data for BORIS-negative
(GM12878, lymphoblastoid cells, ENCODE data) and
BORIS-positive (K562) cells. The genomic regions invar-
iantly occupied by CTCF in both K562 and GM12878 cells
were then separated into two groups (1xCTSes and
2xCTSes) based on BORIS occupancy in K562 cells. The
CTCF ChIP-seq tag density at the two classes of CTCF
bound regions in GM12878 cells demonstrated signifi-
cantly higher CTCF occupancy at the 2xCTSes compared
with 1xCTSes, in agreement with double CTCF occupancy
at 2xCTSes in BORIS-negative cells (Fig. S8a in Additional
file 8). The double occupancy for CTCF was also con-
firmed by DNaseI footprints in BORIS-negative NHDFs
(Fig. 2d; Additional file 6). Similarly to K562 cells, 2xCTSes
but not 1xCTSes were highly enriched with RNAPII,
CAGEs, and active histone marks (H3K4me3, H2AZ, and
H3K27ac) (Fig. 4c; Fig. S8a, b in Additional file 8), suggest-
ing that 2xCTSes were preferentially associated with active
promoters and enhancers in BORIS-negative cells as well
as in BORIS-positive cells (K562). Thus, 2xCTSes are func-
tionally specialized in the epigenome, regardless of their
occupancy by CTCF and/or BORIS.
CTCF and BORIS interactions are involved in the
transcriptional program of germ cells
The genomic binding patterns of CTCF and BORIS in
cancer cells suggest that the heterodimerization between
these two proteins could also be characteristic for germ
cells. CTCF and BORIS are co-expressed during sperm-
atogenesis, with BORIS expression being the highest in
haploid round spermatids compared with other germ
cells [27]. To examine the interplay between BORIS and
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Fig. 4 1xCTSes and 2xCTSes are associated with different epigenetic landscapes in both BORIS-positive (K562) and BORIS-negative (GM12878)
cells. a Gene tracks show the association of CTCF and BORIS bound regions in K562 cells with multiple ENCODE ChIP-seq data. The tracks are
labeled with the names of molecules against which antibodies were directed for ChIP-seq. The gray frames highlight CTCF-only, CTCF&BORIS
and BORIS-only bound regions. b Average tag density (tags/10 million) of multiple factors mapped by ChIP-seq in K562 cells (ENCODE data)
across BORIS-only (blue), CTCF-only (red) and CTCF&BORIS (purple) bound regions mapped in K562 cells. The data were normalized to the number of
mapped reads and binding regions. The names of factors used in ChIP-seq are labeled on the top of each plot. RNAPII RNA polymerase II. c Heatmap
demonstrates the difference between 1xCTSes and 2xCTSes with respect to the enrichment of RNAPII, CAGEs, H3K4me3, H2AZ, H3K27ac, ZNF143, and
SMC3 ChIP-seq tag density at two types of CTCF binding classes in BORIS-negative cells (GM12878)
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CTCF in the native context, we performed ChIP-seq to
determine the occupancy of the two proteins in elutri-
ated mouse round spermatids. Similar to cancer cells,
25 % of CTCF bound regions were co-occupied by
BORIS in round spermatids (Fig. 5a). Importantly, a high
level of conservation was observed for both CTCF and
BORIS bound regions in germ cells (Fig. 5b): 84 %, 76 %
and 77 % of CTCF/BORIS, CTCF-only and BORIS-only
bound regions, respectively, could be aligned to the
human genome. Furthermore, these regions were occu-
pied in the same manner by CTCF and BORIS in K562,
OVCAR8 and Delta47 cells (Fig. 5c; Additional file 9).
The fact that similar patterns of CTCF and BORIS occu-
pancy were observed for the conserved genomic regions
in both human cancer cell lines and mouse germ cells
(Fig. 5c, d; Additional file 9) strongly indicates that
CTCF and BORIS co-occupancy in cancer cells recapitu-
lates the features of germline chromatin.
Fig. 5 Genomic profiling of CTCF and BORIS occupancy in mouse germ cells. a Overlapping of CTCF (red) and BORIS (blue) genomic occupancy
in mouse round spermatids. b Histogram indicates the percentage of conserved mouse CTCF and BORIS bound regions in the human
genome. c Average tag density of CTCF (red) and BORIS (blue) occupancy in K562 cells across the conserved mouse binding regions from (b).
d Gene tracks of CTCF and BORIS occupancy at the Tsp50/TSP50 (Prss50/PRSS50) gene in mouse (round spermatids) and human (K562) cells. e Average
tag density (tags/10 million) of RNAPII, H3K4me3, and H3K27ac mapped by ChIP-seq in mouse testis (ENCODE data) across BORIS-only (blue),
CTCF-only (red) and CTCF&BORIS (purple) bound regions mapped in mouse round spermatids. The data were normalized to the number of
mapped reads and binding regions
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As BORIS bound regions (2xCTSes) were highly
enriched at the active promoters and enhancers in hu-
man cancer cells (Fig. 4), we analyzed the enrichment
of RNAPII, H3K27ac, and H3K4me3 mapped in mouse
germ cells (mouse testis, ENCODE) in correlation with
BORIS-bound regions (CTCF&BORIS and BORIS-only)
and CTCF-only bound regions mapped in round sperma-
tids. Similarly to cancer cells (Fig. 5e), all three marks of
active transcription were significantly enriched at BORIS-
bound regions compared with CTCF-only bound regions,
signifying the involvement of 2xCTSes in germline tran-
scription regulation.
2xCTSes demonstrate distinct functional properties upon
co-binding by CTCF and BORIS or by CTCF homodimers
As 2xCTSes were found more frequently within pro-
moters and enhancers in dramatic contrast to 1xCTSes
(Figs. 4 and 5), we tested whether binding of both CTCF
and BORIS to these regions would have a different im-
pact on transcription compared with CTCF binding
alone. We employed two independent experimental sys-
tems to modulate the level of BORIS protein without
changing the expression of CTCF (Fig. 6a). The intro-
duction of zinc finger nuclease (ZFN), targeting the first
coding exon of the BORIS gene, resulted in high effi-
ciency of BORIS knockout 48 h after transfection (Fig. 6a;
Fig. S10a, b in Additional file 10). However, K562 cells
with mutations in BORIS were eventually depleted with
extended culturing, suggesting a requirement of BORIS
for cell viability or proliferation (Fig. 6b; Fig. S10b–d in
Additional file 10). The latter was a distinct possibility,
as it is known that the K562 cell line can be differenti-
ated into either erythroid or megakaryocytic lineages
[42]. Consistent with this model, K562 cells treated with
ZFN produced significantly fewer colonies compared
with untreated cells when plated in soft agar (Fig. 6c;
Fig. S10e in Additional file 10). Single-cell clones (50
clones) recovered from soft agar, upon analysis for the
efficiency of mutagenesis by CEL-I assay, immunoblotting,
and DNA sequencing, all contained a wild-type BORIS al-
lele, with 20 % of the clones also having one allele of the
BORIS gene mutated (Fig. S10c, d in Additional file 10). A
second round of treatment of mutated clones with ZFN
produced a more severe phenotype with indications of
megakaryocytic differentiation (Fig. 6a), such as the upreg-
ulation of megakaryocytic markers in all mutated single-
cell clones with heterozygous BORIS deletion (Fig. 6d;
data not shown). A full knockout of the BORIS gene in
K562 cells had never been obtained despite multiple at-
tempts (data not shown), indicating that BORIS knockout
could be incompatible with the viability of K562 cells.
However, we clearly established that BORIS is required for
K562 proliferation, as the loss of BORIS led to the differ-
entiation of K562 cells into the megakaryocytic lineage
(Fig. 6a, d). Conversely, the differentiation of K562 cells
into the megakaryocytic lineage by independent means
(i.e., upon phorbol 12-myristate 13-acetate (PMA) treat-
ment led to the dramatic downregulation of BORIS, signi-
fying BORIS involvement in maintenance of K562
multipotency (Fig. S10f, g in Additional file 10).
To directly gauge the involvement of BORIS in the
transcriptional regulation of K562 cells we performed
RNA-seq analysis of K562 upon BORIS depletion.
Hundreds of genes functionally linked to cancer, inflam-
matory response, and/or cell differentiation changed their
expression levels upon BORIS downregulation in K562
cells (Fig. 6e; Tables S1–S3 in Additional file 11). In
particular, the depletion of BORIS in K562 cells resulted
in significant change in transcription of 1035 genes (351
downregulated and 684 upregulated, p < 0.05; Fig. 6e).
The majority of the genes (70 %) that changed transcrip-
tion had either CTCF&BORIS binding (Fisher’s exact test,
p = 0.0095, odds ratio = 1.29) or BORIS-only binding
(Fisher’s exact test, p < 0.0001, odds ratio = 1.3) in the
promoter region (±5 kb from TSSs).
In the second experimental system, we ectopically
expressed BORIS in the cell line MCF7, which does not
normally express this gene (Fig. 6a). Following stable
BORIS expression in two independent clones, we observed
a dramatic change toward a stem-like phenotype (Fig. 6a).
A similar phenotype was described in MCF7 cells upon
loss of WISP2 (Wnt-1-induced signaling protein-2) expres-
sion [43]. Indeed, upon RNA-seq analysis of MCF7 cells
with stable BORIS expression we found a dramatic down-
regulation of WISP2 in clone 1 and almost complete
knockdown of WISP2 in clone 2 (Fig. S10h in Additional
file 10). The ectopic expression of BORIS in MCF7 cells re-
sulted in the deregulation of 2022 (1334 downregulated
and 688 upregulated, p < 0.05) and 2366 (1191 downregu-
lated and 1175 upregulated, p < 0.05) genes in clones 1
and 2, respectively (Fig. 6f). In line with the direct involve-
ment of BORIS in gene regulation in cis, the majority of
genes (55 % in clone 1, 67 % in clone 2 that changed tran-
scription levels upon induced BORIS expression showed
either CTCF&BORIS binding (Fisher’s exact test; clone 1,
p < 0.0001, odds ratio = 1.52; clone 2, p < 0.0001, odds ra-
tio = 1.69) or BORIS-only binding (Fisher’s exact test;
clone 1, p < 0.0001, odds ratio = 1.47; clone 2, p < 0.0001,
odds ratio = 1.47) in the promoter region (±5 kb from
TSSs). The main pathways concordantly up- or down-
regulated in both independent clones were significantly
associated with cancer, inflammatory response, and re-
productive system disease (Fig. 6f; Tables S4–S6 in
Additional file 11).
The detailed comparison of cells with depleted or in-
duced BORIS expression demonstrated the changes in
transcriptional outcomes that strongly correlated with
BORIS levels in both systems (Fig. 6e–g; Tables S7 and
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Fig. 6 (See legend on next page.)
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S8 in Additional file 11). For example, inflammation
pathways were downregulated with induced BORIS ex-
pression in MCF7 cells while being upregulated upon
BORIS downregulation in K562 (Fig. 6e–g; Fig. S10i in
Additional file 10; Tables S7 and S8 in Additional file 11).
Furthermore, the genes involved in megakaryocytic
lineage differentiation were highly upregulated in BORIS-
depleted K562 cells (Fig. 6a, e), while the genes involved
in the differentiation of cells were downregulated in
MCF7 cells upon BORIS expression (Tables S7 and S8 in
Additional file 11).
Comparing the cell lines with differential occupancy
at 2xCTSes also implicated the direct involvement of
BORIS at these regions in transcriptional regulation. As
illustrated in Fig. S10k, l in Additional file 10, the genes
with 2xCTSes where CTCF occupancy (NHDF) was
replaced by CTCF and BORIS co-occupancy (K562,
OVCAR8, Delta47) displayed distinct modes of tran-
scriptional regulation. For example, the testis-specific
promoter of the GAL3ST1 gene was silenced when oc-
cupied by CTCF alone in most BORIS-negative cell
lines, but it was activated in BORIS-positive cells (germ
and cancer) when co-occupied by CTCF and BORIS
(Fig. S10k, l in Additional file 10). Furthermore, the ex-
perimental upregulation or depletion of BORIS led to
an increase or decrease of GAL3ST1 expression, re-
spectively (Fig. 6h, i). Similarly to GAL3ST1, PRAME
and FOXA3 genes were also silent under CTCF occu-
pancy, but were activated upon CTCF and BORIS co-
binding in both cancer and germ cells (Fig. S10k, l in
Additional file 10). An opposite occupancy-specific ef-
fect was observed for the EGR1 promoter, which was
highly active under CTCF homodimer occupancy in
MCF7 cells but was dramatically repressed upon ec-
topic BORIS expression (Fig. 6h, i). Two more examples,
BBC3 and FGFR4, showed dissimilar transcriptional
outcomes depending on 2xCTS occupancy by CTCF and
BORIS (Fig. 6h, i). Thus, these analyses showed that
CTCF&BORIS co-regulation of corresponding genes is of
critical importance for the transcriptional program of both
germ and cancer cells, and represents a functionally dis-
tinct mode of transcription control compared with CTCF
homodimer bound at the same regions.
We also found some revealing examples of CTCF&BORIS
controlled genes that changed their expression in the
same way upon both BORIS induction and depletion:
BBC3 was upregulated and EGR1 downregulated
(Fig. 6h, i). This could be explained either by an indir-
ect effect of BORIS balance or by BORIS regulation im-
plemented through long-range chromatin interactions.
The latter is an intriguing option, as the potential role
of BORIS in three-dimensional folding of chromatin
had never been >possibility we cross-referenced our
ChIP-seq data with a published RNAPII ChIA-PET
study where 30,000 K562-specific loops were mapped
in BORIS-positive cells (K562) versus BORIS-negative
cells (MCF7) [44]. CTCF&BORIS bound regions were
notably overrepresented (65 %) at the anchors of K562-
specific loops (Fig. S11a in Additional file 12). More
importantly, the same regions were occupied by CTCF
and RNAPII in MCF7 cells, but the long-range interac-
tions were different (Fig. S11b, c in Additional file 12).
Thus, BORIS may re-wire the long-range chromatin in-
teractions mediated by CTCF in BORIS-negative cells
through CTCF and BORIS heterodimerization in
BORIS-positive cells (the proposed model is presented
in Fig. S11d in Additional file 12).
Clustered CTCF motifs are associated with specific
chromatin architecture in human and mouse sperm
As shown here, CTCF and BORIS were co-localized in
vivo in postmeiotic haploid round spermatids (Fig. 5).
(See figure on previous page.)
Fig. 6 CTCF and BORIS interactions are essential for transcriptional regulation in cancers. a Two models are used in the study: K562 cells (BORIS
+/+) treated with zinc finger nuclease (ZFN) to knockout/downregulate the BORIS gene (BORIS+/−) and MCF7 cells with stably transfected empty
vector (MCF7+EV) or BORIS-expressing vector (MCF7+BORIS). Upon stable change of BORIS expression (western blot) both types of cells showed
phenotypic changes. b Western blot analysis of K562 cells (mass culture) upon BORIS depletion by ZFN (before ZFN (wt), 48 h, and two weeks
after ZFN). c Number of K562 single-cell clones growing in soft agar after ZFN transfection (ZFN) compared with untransfected cells (Control). d
Expression of megakaryocytic lineage markers in three independent single-cell K562 clones after ZFN treatment compared with wild type (wt). e,
f Fold changes (log2) in gene expression in response to BORIS depletion in K562 cells (e) and BORIS induction in MCF7 cells (f). Two independent
single-cell clones of MCF7 cells with stably expressed BORIS were analyzed (f). Top associated diseases and bio functions (p < 0.0001) are shown
for upregulated (red) and downregulated (green) genes on the right (Ingenuity Pathway Analysis). The genes that change expression in a similar
way in both independent MCF7 clones with stably transfected BORIS are shown on the heat map (f). g Heat map showing the comparison of
genes that changed expression upon BORIS depletion (K562 cells) and BORIS induction (MCF7 cells, clone1) in respect to diseases and bio
functions (activation z-score). h Genome browser view of six CTCF&BORIS target genes. The tracks are labeled with the names of molecules
against which antibodies were directed and the cell lines used in ChIP-seq, respectively. The red arrows show the beginning and direction of
transcription. The schematic occupancy of promoters with either CTCF (red) and BORIS (blue) heterodimers or CTCF homodimer is shown on the
right. i Expression of six CTCF&BORIS targets from panel (h) was analyzed by quantitative PCR in cells with upregulated (MCF7+BORIS) and
downregulated BORIS (BORIS small interference RNA (si) treatment of K562 cells, mass culture) expression. Asterisk (*) represents p-value <0.05
and double-asterisk (**) represents p-value <0.01 between treated and untreated cells (c, i). Error bars represent standard deviation of the average
of triplicate measurements (c, d, i). TSS transcription start site
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Round spermatids undergo an extensive chromatin re-
modeling process during their final differentiation into
mature sperm. During these processes DNA is packaged
into a highly condensed state in which the somatic
histones are replaced by protamines. However, a small
proportion of histones remains associated with DNA
and there are several reports suggesting CTCF associ-
ation with these regions [45–48]. In order to understand
the biological function of 2xCTSes during male germ
cell development, we compared the two classes of CTCF
binding regions with the genomic loci that escape pro-
tamine occupancy in mature human and mouse sperm.
For that we used a published data set of MNase foot-
prints mapped in human and mouse sperm [49, 50]. The
overlap between our set of data for CTCF and BORIS
occupancy in cancers with the regions of histone retained
in human sperm showed the specific enrichment of his-
tones at 2xCTSes, but not at 1xCTSes (Fig. 7a, b). To ex-
tend this observation further, we analyzed the enrichment
of histones retained in sperm at two classes of CTCF
binding regions: 2xCTSes (CTCF&BORIS, BORIS-only)
and 1xCTSes (CTCF-only). We found that in both human
and mouse sperm, the histones were indeed specifically
retained at BORIS-bound regions (Fig. 7c, d), but not at
CTCF-only bound regions. These results suggest that oc-
cupancy of BORIS at 2xCTSes may be implicated in chro-
matin remodeling during the differentiation of round
spermatids, where BORIS is highly expressed, and may
mark the regions where the histones have to be retained
to label genes, promoters, and enhancers destined for
early expression in the developing embryo.
Discussion
ChIP-seq analysis of several BORIS-expressing cancer
cell lines established that the pattern of BORIS binding
is similar across cell lines of independent origin and
thus likely reflects an underlying “encoding” of the
binding regions for their propensity to bind BORIS
(Fig. 1; Additional file 1). Upon further analysis, we un-
covered that this encoding largely reflects the ability of
these regions to be co-bound by CTCF and BORIS and/
or by BORIS or CTCF homodimers. Such regions,
mapped by ChIP-seq as single peaks, encompass two or
more closely spaced CTCF binding DNA sequences/
motifs (used here interchangeably as 2xCTS or clus-
tered CTSs). We further showed that structural proper-
ties of 2xCTSes and single CTCF sites (1xCTSes)
correlate with functional differences: 2xCTSes are pref-
erentially associated with promoters and enhancers,
confer differential modes of transcriptional regulation
depending on the occupancy by CTCF and/or BORIS,
and correlate with regions that retain histones during
spermatogenesis.
Genome-wide analysis of BORIS distribution reveals the
inherent structural dichotomy between clustered CTCF
binding sites and single CTCF binding sites
Our present analysis of BORIS distribution in chromatin
of cancer cells (Fig. 1), in addition to providing a wealth
of information on the involvement of BORIS in tran-
scriptional regulation and chromatin organization, inad-
vertently revealed inherent differentiation of CTSes.
Approximately one-third of CTCF binding regions iden-
tified by ChIP-seq as single peaks encompassed at least
two closely spaced CTSes (Fig. 2). The 2xCTSes were
predisposed to bind BORIS in cooperative fashion with
CTCF (CTCF&BORIS), as well as comprised the major-
ity of BORIS-only sites (Fig. 2; Additional files 1, 2, and
3). Notwithstanding that their genome wide-distribution
was revealed by the present BORIS analysis, the emer-
gence of 2xCTSes evidently predated the appearance of
BORIS in evolution. The existence of these clustered sites
was demonstrated in our previous work on EMSA map-
ping of CTCF binding [32, 51]. With longer (150–200 bp)
EMSA probes, we repeatedly detected either one or two
DNA–protein complexes with the 11 ZF DNA binding
domain of CTCF ([32, 51, 52] and unpublished observa-
tion). Further analyses of a subset of CTCF targets uncov-
ered the corresponding presence of either one or two
CTSes within the probes [32, 51]. For example, the Fab-8
Drosophila chromatin insulator was found to encompass
two closely spaced CTSes [51], while the testis-specific
promoter of TSP50 was shown to include two adjacent
CTSes, conserved between mouse and human [32]. The
published examples of two closely spaced CTSes, as we
now know, include alternative BORIS promoters [34],
mouse KvDMR1 imprinting locus [52], BAX promoter
[53], enhancers of the murine Igh locus [54], and others
[55]. The principal biological significance of clustered
CTSes can be seen in their evolutionary conservation. For
example, the two adjacent CTSes in the PRSS50/TSP50
promoter are highly conserved, and the CTCF-binding
motifs are arranged similarly in human and mouse pro-
moters (Fig. 2a). In the TP53/Tsp53 promoter, the two
CTCF sites are arranged in opposite directions, yet in a
very similar way in both human and mouse (Fig. S4b in
Additional file 4).
The structural difference of clustered CTSes from
1xCTSes is based on the number, i.e., two or more, of ZF-
bound DNA motifs. The existence of clustered CTSes is
also likely constrained by the requirement for close spa-
cing of DNA motifs, as suggested by their single-peak
appearance in ChIP-seq (Fig. 3a). The widespread gen-
omic occurrence of clustered sites was not revealed until
the present work, largely due to the insufficient resolution
of ChIP-seq experiments and the perception in published
studies that all CTCF ChIP-seq peaks comprise a single
CTCF motif [56].
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In this work, we present evidence that 1xCTSes are
preferentially occupied by CTCF only and contain a single
CTCF binding motif, while clustered CTSes, which en-
close two or more CTCF-binding motifs, are preferentially
occupied by larger/multimeric complexes, including
CTCF&CTCF, CTCF&BORIS, or BORIS&BORIS (Fig. 2;
Additional files 3, 4, and 5). This model is supported by
the demonstration of the presence of at least two CTCF
motifs and at least two DNaseI footprints in the regions
with 2xCTSes (Fig. 2d; Additional file 6), as well as by the
conservation of two juxtaposed CTCF motifs according to
phastCons score (Additional file 6). Additionally, we
showed that clustered CTSes predispose the physical in-
teractions of CTCF and BORIS (Fig. 3). Further, results
from EMSA (Fig. 3f; Fig. S5c in Additional file 5), ChIP-
Re-ChIP (Fig. 1i; Fig. S2b in Additional file 2), co-
immunoprecipitation (Fig. 3b), and ISPLA in both cancer
and germ cells (Fig. 3c, d, i) support the co-occupancy
of 2xCTSes by CTCF and BORIS. The discovery of
2xCTSes adds an additional layer of complexity to the
versatility of CTCF, and likely BORIS, as multifunctional
chromatin factors. The CTCF, a multifunctional protein it-
self [12], employs variable combinations of 11 ZFs to bind
a wide range of DNA sequences, which form an extensive
array of motifs [13, 56]. In that context, the clustered
CTSes, with variable spacing, orientation, and the number
of binding sites that are bound by several CTCF and/or
BORIS molecules, would confer a substantially higher de-
gree of versatility to the regulatory potential of CTCF and/
or BORIS. These chromatin regions likely have a higher
degree of combinatorial usage of ZFs, stronger binding,
more cooperative protein–protein interaction, a wider
Fig. 7 BORIS bound regions correlate with histone retention in human and mouse sperm. a Gene tracks show the distribution of histones
retained in human sperm in association with CTCF and BORIS bound regions, mapped in K562, Delta47 and OVCAR8 cell lines. The name of the
molecules against which antibodies were directed and the cell lines used in ChIP-seq are shown on the left. b Heatmap indicates the enrichment
of histones retained in human sperm at 2xCTS regions (invariant BORIS binding in K562, OVCAR8, and Delta47). c, d Average tag density (tags/10
million) of histones retained in human (c) and mouse (d) sperm across BORIS-only (blue), CTCF-only (red) and CTCF&BORIS (purple) bound regions
mapped in K562 cells (c) and mouse round spermatids (d). The data were normalized to the number of mapped reads and binding regions
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spectrum of protein partners, and likely more selective in-
teractions with other anchors of chromatin loops com-
pared with single sites.
2xCTSes as a transcriptional platform modulated by BORIS
The discovery of clustered CTSes enables us, for the first
time, to address the long-standing question of how
CTCF can serve in the context of the same nucleus as a
bona fide transcription factor, while maintaining a sub-
stantial presence at putative insulator/boundary sites
that bear no indications of transcriptional activity [1].
Indeed, only 10–20 % of all CTCF binding regions are
located in promoter regions in any given cell type [14,
57], while the rest of the CTSes are not associated with
TSSs. The obvious candidates for the determinants of
such distinct functional roles would be DNA sequences
themselves and/or differential identity of chromatin at
these two types of sites. Here, we present genome-wide
evidence that DNA sequences underlying the two types
of CTSes are structurally different, i.e., that not all CTCF
bound regions are equal. It is exemplified by the finding
that only clustered CTSes, but not 1xCTSes, were asso-
ciated with active promoters and enhancers in both
cancer and germ cells (Figs. 4 and 5). Thus, one could
hypothesize that the role of CTCF, and likely BORIS, as
transcription factors is implemented through 2xCTSes.
As with other transcription factors, that role could be
further modulated by the interactions with additional
proteins [58–63]. Furthermore, in case of CTCF and/or
BORIS serving in a transcription factor capacity, their
potential to regulate gene expression may also involve a
formation of chromatin loops (Additional file 12).
The question that remains open is what mechanism
facilitates BORIS replacement of CTCF at clustered
CTSes to form CTCF&BORIS and BORIS-only bound
regions. The originally proposed model for BORIS’ “in-
vasion” of CTSes upon its expression in germline and
cancers was that BORIS simply outcompetes CTCF for
binding at some sites [27, 30]. However, based on the
present genome-wide study, it is more likely that
BORIS outcompetes CTCF from one out of two closely
spaced binding sites at the majority of 2xCTSes, there-
fore replacing CTCF homodimer with a more stable
CTCF&BORIS heterodimer, and that BORIS-only
bound regions represent the next step in the full re-
placement of CTCF by BORIS. The outcome of CTCF
and BORIS homodimer and heterodimer occupancy at
2xCTSes is different with respect to transcriptional
regulation and, possibly, transcriptional loop formation
(Fig. 6; Additional files 10 and 12). In contrast to clus-
tered CTSes, the 1xCTSes evidently are preferentially
located intergenically and associated with genomic re-
gions devoid of hallmarks of active transcription (Fig. 4;
Additional files 7 and 8). These characteristics may be
consistent with chromatin barrier/insulator elements.
BORIS binding to DNA and its putative regulatory
function in cancer cells is causally related to CTCF&BORIS
and BORIS-only bound regions in the germline
CTCF is ubiquitously expressed in all types of cells, while
BORIS expression is normally restricted to germ cells and
could be aberrantly activated in cancers [27, 35, 38]. The
aberrant activation of cancer testis genes, especially global
regulators such as BORIS, could be a substantial compo-
nent of reprogramming normal somatic cells into malig-
nant ones. Here we demonstrate that the core binding
pattern of BORIS distribution in three independent cell
lines that tolerate high levels of endogenous BORIS is
probably rooted in the normal function of BORIS itself
and its interaction with CTCF in the germline. This con-
clusion is primarily based on our finding that the genome-
wide occupancy of 1xCTSes and 2xCTSes by CTCF and
BORIS in cancer cells largely recapitulates their binding
profile in germ cells, at least for the subset of binding
regions that are conserved between mice and humans
(Fig. 5; Additional file 9).
As clustered CTSes were strongly associated with tran-
scription (Fig. 4) and enriched for active enhancer and
promoter epigenetic marks (Figs. 4 and 5e), it was logical
to hypothesize that BORIS binding and/or BORIS het-
erodimerization with CTCF at clustered CTSes may ini-
tiate or at least predispose cancer cells for the actual
execution of a germline-like transcription program. In-
deed, upon examining the actual effect of BORIS dosage
on the transcription of genes associated with clustered
CTSes, we found that the substitution of CTCF homodi-
mer by CTCF and BORIS heterodimer at the 2xCTSes is
required for the expression of some testis-specific genes
(Fig. 6; Fig. S10k, l in Additional file 10). Furthermore,
using two independent systems modulating BORIS levels
in opposing directions, we demonstrated that the tran-
scription of genes regulated by BORIS is actually
dependent on BORIS dosage for most cases, suggesting
the direct mode of regulation (Fig. 6). The mechanism
of this predisposition of cells aberrantly expressing
BORIS to the germline-specific transcriptional config-
uration of the epigenome and, to some degree, tran-
scriptome (Fig. 6) is likely implemented via chromatin
loops specific for BORIS-bound clustered sites (Additional
file 12). This finding opens a new chapter in our under-
standing of CTCF-mediated chromatin loop organization
genome-wide, as it assigns this crucial CTCF function to a
specific subset of CTSes, namely clustered CTSes. The ac-
tual levels of transcriptional activation of germline-specific
genes controlled by clustered CTSes bound by BORIS in
cancer cells can be, of course, additionally dependent on
other factors known to be deregulated in cancers, such as
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DNA methylation and the expression of other tissue-
specific transcription factors. For example, while the
TSP50 gene is controlled by the clustered CTS bound by
CTCF and BORIS in both human and mouse germ cells
(Figs. 2a and 5d), its activation required the full demethyl-
ation of the promoter region [32].
A putative novel function of 2xCTSes in normal
postmeiotic germ cells
Understanding the functional role of BORIS in cancer is
hardly possible without learning more about its normal
function. While the role of BORIS as transcriptional acti-
vator of spermatogenesis-specific genes has been estab-
lished [29, 30, 32], there are additional observations that
require more extensive analyses. One such phenomenon
is the role of BORIS in postmeiotic cells, where BORIS ex-
pression is highest, based on mRNA levels [29]. However,
the previous assessment of green fluorescent protein-
BORIS protein distribution in transgenic mice indicated
that, while its level is high in spermatogonia and prelepto-
tene spermatocytes, it is below recordable levels in post-
meiotic cells [30]. The reliable detection of untagged/
native BORIS protein is particularly challenging due to the
lack of reliable commercial antibodies, which is exempli-
fied by the false positive detection of BORIS expression in
somatic tissues [64]. Our results with newly generated
anti-mouse BORIS polyclonal antibodies confirmed the
expression of BORIS in round spermatids (Fig. 5a),
where a wave of postmeiotic transcription and chromatin
remodeling takes place to produce mature spermatozoa.
Concomitantly, chromatin becomes more condensed, and
histones are replaced by protamines, with only 5–10 %
of the sperm’s epigenome still packaged with histones
[45–50, 65–69]. The regions that retained histones have
been reported to be essential for the expression of
genes related to early zygotic activation [47, 48, 50].
Moreover, the presence of CTCF protein in mouse and
human sperm has been reported previously [70]. In
addition, several reports have shown the presence of
the CTCF motif and correlation with CTCF bound
regions in different cells lines with MNase footprints
released by micrococcal nuclease digestion in human
and mouse sperm [45–47]. Although our results concur,
we found that not all CTCF binding regions are correlated
with histone retention in sperm, but 2xCTSes specifically.
Those regions are either co-occupied by BORIS only or by
both CTCF and BORIS in round spermatids and, likely, in
sperm. Those regions also could correlate with testis-
specific histones that escape histone-to-protamine re-
placement in mature sperm [71]. These results raise the
intriguing possibility that BORIS plays a regulatory role in
sperm genome organization and gene expression during
early development. However, data produced by us and
others do not show direct binding of CTCF and BORIS to
the sperm genome. Future studies with ChIP-seq data
of BORIS and CTCF in human sperm will be needed to
analyze if the presence of both proteins may play a role
in the regulation of the gene expression on zygotic gene
activation and whether both proteins bound to sperm
chromatin are important for gene expression during
development.
Conclusions
Our study provides the first comprehensive analysis of
CTCF and BORIS occupancy in cancer and germ cells,
where the two paralogous proteins are co-expressed. In
this study we found that BORIS binds to approximately
one-third of CTCF bound regions, representing clus-
tered CTCF binding sites, while the remaining two-
thirds consist of single CTCF binding sites and are occu-
pied by CTCF alone in vivo. Thus, the pattern of BORIS
binding uncovered two classes of CTCF binding regions
that are preprogrammed and evolutionarily conserved in
DNA sequence. Our study challenges the perception in
the current literature that all CTCF sites are equal and
characterized by a single CTCF motif. The clustered
CTCF binding sites constrain CTCF to form homodi-
mers in normal somatic cells and heterodimers with
BORIS in germ and cancer cells expressing BORIS. The
drastic enrichment of clustered CTCF binding sites at
active promoters and enhancers confirms their func-
tional significance in transcription. In male germ cell de-
velopment, clustered CTCF binding sites are associated
with a unique chromatin composition in sperm, likely
presetting these regions for zygotic gene activation.
Materials and methods
Cell culture
K562, Delta47, OVCAR8, NHDF, and MCF7 cell lines
were grown in Dulbecco's modified Eagle medium
(DMEM) supplemented with 10 % fetal calf serum and
penicillin-streptomycin. MCF7 cells were transfected
using the Cell Line Nucleofector® Kit V (program P-020;
Lonza Group Ltd) and the vector (pCpGvitro-hygro, Invi-
voGen) encoding either LacZ (empty vector) or the open
reading frame (ORF) of BORIS. After 3 weeks of hygro-
mycin selection (150 mg/l), several single-cell clones stably
growing under antibiotic selection were selected and ana-
lyzed by western blot for the presence of BORIS exogen-
ous expression (data not shown). To knockdown BORIS
expression, K562 cells were transfected using Cell Line
Nucleofector® Kit V (program T-016; Lonza Group Ltd)
with either small interfering RNA (siRNA) control or with
BORIS SMART pool siRNAs (Dharmacon, Inc.) or with
ZFNs, targeting the first coding exon of the BORIS gene.
ZFNs targeting the BORIS gene were designed and vali-
dated by CompoZr® Custom ZFN Service (Sigma-Aldrich
Life Science, St Louis, MO, USA). Capped ZFN mRNAs
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were produced from linearized plasmid DNA by in vitro
transcription with MessageMAX™ T7 ARCACapped Mes-
sage Transcription Kit and purified by MEGAclear™ Kit
(Sigma-Aldrich). The two ZFN mRNAs were combined in
equal amounts for gene knockout and delivered to the
cells by transfection. As a control we used a single ZFN
mRNA. ZFNs were validated for genome editing activity
by transient transfection into K562 cells and measurement
via the Surveyor Nuclease Assay for endogenous activity.
Round spermatids were purified by centrifugal elutriation
[72] followed by flow cytometry sorting of cells stained
with Vybrant DyeCycle Green (Invitrogen, Carlsbad, CA,
USA) to obtain cell fractions with high purity. Briefly,
decapsulated testis were treated with collagenase followed
by treatment with trypsin, and the dissociated cells were
used for centrifugal elutriation. Partially purified sper-
matocytes and round spermatid fractions were incubated
with 10 μM Vybrant DyeCycle Green for 30 min at 32 °C
followed by 4,6-diamidino-2-phenylindole (DAPI) stain-
ing. Cells were then sorted on a FACSAria (Becton Dick-
inson) to purify spermatocytes and round spermatids.
DAPI-positive dead cells were eliminated. The purity of
cells was confirmed by flow cytometry analysis of DNA
content. All animal experiments were performed at the
NIH/Bethesda, in compliance with the guidelines of the
Institutional Animal Care and Use Committee of the
National Institute of Allergy and Infectious Diseases
(NIAID).
ChIP sequencing
For ChIP-seq 108 asynchronously growing cells were
crosslinked with 1 % formaldehyde for 10 min at room
temperature, followed by quenching with 125 mM
glycine for 10 min, washed twice with 1× phosphate
buffered saline (PBS), and resuspended in chromatin
immunoprecipitation (ChIP) lysis buffer (150 mM
NaCl, 1 % Triton X‐100, 0.1 % SDS, 20 mM Tris–HCl
pH8.0, 2 mM EDTA). Chromatin was sheared to an
average length of 200–500 bp using a Bioruptor sonica-
tor. After overnight incubation with DiaMag magnetic
beads (Diagenode, Inc.) and CTCF or BORIS monoclo-
nal or polyclonal antibodies (characterized and de-
scribed by us [29, 32, 39]), precipitated chromatin was
then washed, de-crosslinked, and digested with protein-
ase K. The resulting DNA was purified using phenol/
chloroform/isoamyl alcohol. DNA concentration was
assessed with a Quant‐it PicoGreen dsDNA kit (Invitro-
gen) and 5–10 ng was used to generate sequencing
libraries. ChIP DNA was amplified using a TruSeq ChIP
Sample Preparation Kit (Illumina, Inc., USA). Briefly,
the immunoprecipitated material was end-repaired, A-
tailed, ligated to the sequencing adapters, amplified by
15 cycles of PCR, and size selected (200–400 bp)
followed by single end sequencing on an Illumina
Genome Analyzer according to the manufacturer’s
recommendations.
ChIP-Re-ChIP
Chromatin was prepared as for ChIP-seq as described
above. First, chromatin was immunoprecipitated using
BORIS monoclonal antibodies, which were chemically
crosslinked to magnetic beads using crosslinking buffer
(0.2 M triethanolamine pH 8.2, 20 mM DMP), 30 min at
room temperature. After overnight incubation with
crosslinked antibodies, the chromatin was washed and
eluted twice using elution buffer (0.1 M glycine-HCl
pH 2.5). Eluted chromatin was neutralized using 1 M
Tris (pH 8) and used for the second round of ChIP with
CTCF monoclonal antibodies following the standard
ChIP protocol as described above. The sequencing li-
braries were prepared as described above.
Bioinformatic analysis of ChIP-seq data
Sequences generated by the Illumina genome analyzer
(36 and 50 bp reads) were aligned against either the hu-
man (build hg19) or mouse (build mm9) genome using
the Bowtie program [73]. The alignment was performed
with default parameters except the sequence tags that
mapped to more than one location in the genome were
excluded from the analysis using the –m1 option. Peaks
were called using Model-based Analysis for ChIP-seq
(MACS) [74] using default parameters. After MACS, we
applied the Peak Splitter algorithm (part of MACS) to
call sub-peaks and summits of peaks and improve peak
resolution. The ChIP-seq data were visualized using the
Integrative Genomics Viewer (IGV) [75]. The peak over-
laps between CTCF and BORIS ChIP-seq data sets were
determined with BedTools Suite [76]. We defined peaks
as overlapping if at least 1 bp of reciprocal peaks inter-
sect (CTCF&BORIS); the remaining peaks were defined
as non-overlapping (CTCF-only and BORIS-only). The
normalized tag density profiles were generated using the
BedTools coverage option from the BedTools Suite, nor-
malized to the number of mapped reads, and plotted by
Microsoft Excel. The heatmaps were generated using the
seqMINER 1.3.3 platform [77]. We used either k-means
ranked or linear method for clustering normalization.
The summits of either CTCF or BORIS peaks were ex-
tended ±5 kb. seqMINER was also used to generate the
average profiles of read density for different clusters.
Position weight matrices for CTCF and BORIS bound
regions were searched using Multiple EM for Motif
Elicitation (MEME) software [78]. The sequences under
the summit of either CTCF or BORIS peaks extended
100 bp upstream and downstream were used for motif
discovery. We ran MEME with parameters (−mod oops
-revcomp -w 20) to identify 20-bp-long motifs considering
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both DNA strands. To analyze the occurrence of CTCF
motifs in the sequences occupied by either CTCF or
BORIS or both proteins at the same time, we used FIMO
software (MEME suite) with default parameters. The pos-
ition weight matrices found for CTCF binding regions by
MEME were used for FIMO software. Each CTCF motif
occurrence had a p value < 0.0001 in the sequences of
200 bp around the summit of either CTCF (CTCF-only,
CTCF&BORIS bound regions) or BORIS (BORIS-only
bound regions) peaks. For evolutionary conservation ana-
lysis, all pre-computed phastCons scores were obtained
from the University of California, Santa Cruz (UCSC) gen-
ome browser [79]. Genomic distribution of CTCF and
BORIS ChIP-seq peaks relative to reference genes was
performed using the Cis-regulatory Element Annotation
System (CEAS) [80]. All ChIP-seq data have been depos-
ited in the Gene Expression Omnibus (GEO) repository
with the following accession number [GEO:GSE70764].
RNA-seq experiments
Two platforms were used for RNA-seq: Illumina for
MCF7 and Ion Torrent for K562. For Illumina sequen-
cing, total RNA was extracted from cells using Trizol
(Life Technologies) according to the protocol provided
by the manufacturer. The RNA quality was assessed
using the Agilent Bioanalyzer 2100. The RNA sequen-
cing library preparation and sequencing procedures were
carried out according to Illumina protocols with minor
modifications. Briefly, poly(A)-mRNA was purified from
10 μg of RNA with streptavidin-coated magnetic beads.
After chemical fragmentation, mRNA fragments were
reverse-transcribed and converted into double-stranded
cDNA. Following end repair and A-tailing, paired-end
adaptors were ligated to the ends of the DNA fragments.
The ligated products were purified on 2 % agarose gels,
and 200–250-bp fragments were selected for down-
stream enrichment by 18 cycles of PCR followed by
purification using a QIAquick PCR purification kit (Qia-
gen). The enriched libraries were diluted to a final con-
centration of 5 nM. Each sample was subjected to
50 cycles of sequencing from a single end in Illumina
Hiseq2000 Sequencer. For Ion Torrent sequencing,
rRNA-depleted RNA was prepared using the RiboMinus
Eukaryote System v2 kit (Life Technologies) according
to the manufacturer's recommendations. rRNA-depleted
RNA (500 ng) was used for library preparation using the
Ion Total RNA-seq v2 kit. The enriched libraries were
diluted to a final concentration of 11 pM and subjected
to sequencing from a single end in a Ion Proton
Sequencer.
Bioinformatic analysis of RNA-seq data
For the Illumina libraries, FASTQ files were mapped to
the UCSC Human reference (build hg19) using TopHat2
with the default parameter setting of 20 alignments per
read and up to two mismatches per alignment. For Ion
Torrent sequencing, FASTQ files were mapped to the
UCSC Human reference (build hg19) using two-step
alignments. First, the reads were aligned with TopHat2.
Second, the unmapped reads from the first step were
then extracted and aligned with Bowtie2 with –local
mode and the –very-sensitive-local option. In both cases,
Illumina and Ion Torrent, the resulting aligned reads
(BAM files) were then analyzed with Cufflinks 2.0.0 to
estimate transcript relative abundance using the UCSC
reference annotated transcripts (build hg19). The ex-
pression of each transcript was quantified as the number
of reads mapping to a transcript divided by the tran-
script length in kilobases and the total number of
mapped reads in millions (FPKM). RNA-seq data have
been deposited in the GEO repository with the following
accession number [GEO:GSE70764].
Published next-generation experiments
ENCODE data for K562 and GM12878 cell lines were
used in the study. The list of genomic coordinates for
active enhancers (17798) in K562 cells was obtained
by overlapping the two sets of ENCODE data
[H3K27ac_K562, Bernstein (Broad Institute); p300_K562,
Snyder (Stanford)]; overlapping regions that showed the
highest enrichment of ChIP-seq tag density of both data
sets compared with input were selected. The list of super
enhancers (742) was adopted from [41]. The list of active
promoters (17,656) was obtained by overlapping of TSSs
(RefSeq genes, hg19) extended 2 kb upstream and
downstream with the two sets of ENCODE data
[H3K4me3_K562, Bernstein (Broad Institute) and
RNAPII_K562 Myers (Hudson Alpha)]; the regions
positive for both marks were selected.
Western blotting and immunoprecipitation
Protein extracts were prepared by lysing K562 cells in
RIPA Lysis buffer (Millipore) containing 50 mM Tris–
HCl, pH 7.4, 1 % Nonidet P-40, 0.25 % sodium deoxy-
cholate, 500 mM NaCl, 1 mM EDTA, 1× protease in-
hibitor cocktail (Roche Applied Science). For
immunoprecipitation analysis, 1.5 mg of total protein
was incubated with BORIS monoclonal antibodies,
CTCF monoclonal antibodies, or mouse IgG overnight
at 4 °C with and without ethidium bromide (100 μg/μl),
followed by incubation with 50 μl of Dynabeads M-280
sheep anti-mouse IgG (Life Technologies) for 1 h at
room temperature. The immunoprecipitates were col-
lected using a magnetic rack and washed five times with
PBS and 0.1 % bovine serum albumin and dissolved in
sample buffer for SDS-PAGE. Immunoprecipitated sam-
ples were resolved by SDS-PAGE, transferred to a PVDF
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membrane, and incubated with the indicated antibodies.
Detections were performed using ECL reagents.
Electrophoretic mobility shift assay
DNA fragments encompassing ~200-bp-long sequences
derived from either CTCF or BORIS ChIP-seq peaks
were synthesized by PCR. The list of primers used in the
study is in Additional file 13. In all cases, sequences of
PCR fragments were confirmed by sequencing. EMSA
was performed as previously described [39]. Briefly, PCR
fragments were labeled using 32P-γ-ATP with T4 poly-
nucleotide kinase (New England, Biolabs). Protein–DNA
complexes were incubated for 1 h at room temperature in
binding buffer containing 25 mM Tris pH 7.4, 0.1 mM
ZnSO4, 5 mM MgCl2, 5 % Nonidet P-40 in PBS, 0.25 mM
mercaptoethanol, 10 % glycerol and 0.5 μg of poly dI-dC.
Protein–DNA complexes were separated from the un-
bound probe using 5 % native polyacrylamide gels (PAAG)
or 1.2 % agarose gels run in 0.5× Tris-borate-EDTA buffer.
Full-length CTCF, full-length BORIS and CTCF 11 ZF do-
main were translated in vitro using the TnT Quick
Coupled Transcription/Translation System (Promega).
Nuclear protein extracts were prepared as described in
[81]. Pichia CTCF was obtained from AAVostrov [82].
In situ proximity ligation assay
Cells seeded on chamber slides (Nunc™ Lab-Tek™ II
Chamber Slide™ System), were fixed in 4 % paraformalde-
hyde for 10 min at 37 °C. Slides were then blocked in 3 %
bovine serum albumin (Sigma) in a humidity chamber for
1 h at 37 °C and incubated overnight at 4 °C with mouse
and rabbit antibodies: custom monoclonal anti-BORIS
and rabbit anti-CTCF (D31H2) (Cell Signaling) in block-
ing solution. After washing, the slides were incubated with
Duolink PLA Rabbit MINUS and PLA Mouse PLUS
probes (Olink Bioscience). Ligation and detection were
performed using the Duolink reagents kit (Olink Bio-
science) according to the manufacturer’s protocol. Fluor-
escence was detected using a Zeiss Plan Apochromat
microscope with a ×63/oil objective. Images were acquired
with an Axiocam MRm camera and Imaris software (Bit-
plane, Co.). The original microscopic images were depos-
ited to Zenodo [83] (10.5281/zenodo.21405).
Immunofluorescent cell staining
Cells plated onto poly-L lysine coated glass cover slips
were fixed with 4 % paraformaldehyde, then washed with
PBS. The cells were permeabilized with 0.1 % Triton X-
100/PBS for 10 min and subsequently incubated with
primary antibodies (anti-CTCF rabbit polyclonal and
anti-BORIS mouse monoclonal antibodies; Cell signal-
ing, Inc., Customized). The cells were further probed
with fluorescein Texas Red and Alexa Fluor 488 tagged
secondary antibodies. DAPI was used for the nuclear
counterstain. The fluorescence was recorded using a
fluorescence microscope (Zeiss LSM 780). The original
microscopic images were deposited to Zenodo [83]
(10.5281/zenodo.21405).
RT-PCR and quantitative PCR
Total RNA was prepared using an RNeasy minikit (Qia-
gen, Valencia, CA, USA). cDNA was prepared using the
SuperScript III first-strand synthesis system (Invitro-
gen) according to the manufacturer’s protocol. Quanti-
tative PCR was performed using SYBR green PCR
master mix (Applied Biosystems, Foster City, CA, USA)
and the 7900HT sequence detection system (Applied
Biosystems). The primers used in the study are listed in
Additional file 13.
Additional files
Additional file 1: Fig. S1. CTCF and BORIS occupancy in human cancer
cell lines. a CTCF and BORIS expression in different cell types determined
by quantitative PCR. b Western blot depicts the relative levels of CTCF
and BORIS proteins in nuclear lysates extracted from different cell types.
c K562 and OVCAR8 cells immunostained with antibodies against CTCF
(green) and BORIS (red). The merge panel shows co-localization of CTCF
and BORIS proteins in the nucleus. d EMSA: either in vitro translated
CTCF (CTCF TNT) or BORIS (BORIS TNT) were incubated with 32P-labeled
probe. The first lane is a negative control, containing no protein (Free-F).
The appearance of a shifted band (Super Shift) after adding specific
antibodies demonstrated the specificity of DNA–protein interaction and the
absence of cross-reactivity between CTCF and BORIS antibodies. e, f Venn
diagrams depict the numbers and percentages of CTCF (e) and BORIS (f)
bound regions overlapping in K562, OVCAR8 and Delta47 cells. Heatmap
shows BORIS (e) or CTCF (f) occupancy at the invariant CTCF (47,531) or
BORIS (17,536) bound regions in three cancer cell types. The tag density was
subjected to k-means ranked clustering with two clusters expected. BORIS
binds to roughly 30 % of invariant CTSes, while the remaining 70 % of CTSes
belong to CTCF-only binding regions. e Similar analysis revealed that nearly
70 % of BORIS bound regions showed CTCF occupancy in all three cell lines.
f Invariant BORIS-only regions mapped in K562 and Delta47 cells were
generally occupied by CTCF in OVCAR8 cells (f), marked by bracket. g Venn
diagram depicts the overlapping CTCF bound regions mapped in 38 human
cell lines (ENCODE) with BORIS-only bound regions mapped in K562 cells.
h ChIP-seq tracks show the genomic regions occupied by BORIS alone
in K562 cells (BORIS-only) and by both CTCF and BORIS in OVCAR8 and
Delta47 cells. (PPTX 1854 kb)
Additional file 2: Fig. S2. CTCF and BORIS bind to the same genomic
regions simultaneously. a The distribution of peak intensity for CTCF
(AllCTCF) and BORIS (AllBORIS) bound regions in the K562 cell line. The
peak intensity (tag density) is shown for CTCF peaks that coincide with
BORIS peaks (CTCF&BORIS), for BORIS peaks that coincide with CTCF peaks
(BORIS&CTCF), and for CTCF-only and BORIS-only bound regions. Data are
shown in logarithmic scale; ***p < 0.01. b Genome browser view of CTCF
and BORIS occupancy in K562 and Delta47 cells in combination with
ChIP-Re-ChIP-seq data for K562 and Delta47 cells. The gray frames highlight
CTCF-only, CTCF&BORIS, and BORIS-only bound regions. Only CTCF&BORIS
bound regions were detected in ChIP-Re-ChIP data. (PPTX 121 kb)
Additional file 3: Fig. S3. EMSA demonstrates the presence of two
CTCF binding sites inside BORIS bound regions (CTCF&BORIS and BORIS-
only). a Top panels: ChIP-seq tracks show CTCF and BORIS occupancies
mapped in K562, Delta47 and NHDF cells. From left to right, TP53
promoter represents CTCF&BORIS bound region; seven CTCF sites
residing in the H19-IGF2 imprinting control region are examples of CTCF-
only bound regions; the BMI promoter represents a BORIS-only bound
region; the PROB1 exon illustrates that a BORIS-only bound region
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mapped in K562 cells is a CTCF&BORIS bound region in Delta47 cells.
Bottom panels: binding of in vitro translated 11 ZF domain of CTCF
(11ZF), full-length CTCF (CTCF) and full-length BORIS (BORIS) proteins to
the TP53 promoter, one of seven CTCF sites in the H19-IGF2 imprinting
control region (fourth CTCF binding site), BMI promoter, and PROB1 exon.
In vitro translated luciferase protein was used as a negative control (Luc).
The DNA complexes with 11 ZF domain, CTCF, and BORIS proteins are
indicated by black, red and blue arrows, respectively. The single and
double shifts with 11 ZF domain are shown by single and double black
arrows, respectively. The genomic coordinates (hg19) of DNA probes are
indicated at the bottom of the gels. b, c Five examples of CTCF-only (b)
and BORIS-only (c) bound regions. Upper panel: ChIP-seq tracks show
CTCF and BORIS occupancies at ten genomic regions mapped in K562,
OVCAR8, and Delta47 cells. Lower panel: EMSA with the genomic sequences
shown on the upper panel. In vitro translated 11ZF domain of CTCF (11ZF),
full-length CTCF (CTCF) and BORIS (BORIS) proteins were incubated with the
corresponding CTCF-only and BORIS-only bound regions. The single and
double shifts with 11 ZF domain are shown by single and double black
arrows, respectively. (PPTX 353 kb)
Additional file 4: Fig. S4. CTCF&BORIS bound regions enclose at least
two CTCF binding motifs. a The motifs identified by MEME for CTCF-only,
CTCF&BORIS and BORIS-only bound regions in K562 cells. Additionally,
the presence of the CTCF motif was confirmed in 70 % of BORIS-only
bound regions. b, c The alignment of human and mouse sequences
representing five CTCF&BORIS bound regions (b) and two CTCF-only
bound regions (c). The summits of CTCF and BORIS peaks are highlighted
by red and blue nucleotides, respectively. The CTCF motif is shown in bold
italics and underlined. The CTCF motif is indicated with black and blue
colors, depending on sense and antisense orientation, respectively. d, e
Number of CTCF motifs in the genomic regions, encircling 100 bp upstream
and downstream of the summit of CTCF peaks at CTCF&BORIS bound
regions (d) and from the summit of CTCF-only peaks (e). The histogram
shows the percentage of CTCF binding regions (y-axis) containing 0 to 7
CTCF motifs (x-axis). f The distribution of distances between two CTCF
motifs at 1-bp resolution (x-axis) at CTCF&BORIS bound regions (y-axis). The
CTCF&BORIS bound regions that have only two CTCF motifs under the
peaks were selected for the analysis. (PPTX 3766 kb)
Additional file 5: Fig. S5. CTCF&BORIS bound regions enclose at least
two CTCF binding sites. a Genome browser view of CTCF and BORIS
occupancy at seven CTCF&BORIS (blue bracket) and seven CTCF-only (red
bracket) bound regions in K562 and Delta47 cells. Top panel: at the top of
the genome browser view, the names of sequences are highlighted by
black or red colors, which represent at least two or one CTCF motifs under
the peaks, respectively. Lower panel: EMSA with the corresponding
CTCF&BORIS and CTCF-only binding regions. The ~200-bp 32P-labeled
probes were incubated with either in vitro translated luciferase (−) or
with 11 ZF CTCF domain (11ZFs). The slower (shown by arrow with two
red dots) and faster (arrow with one red dot) migrating shifted bands
correspond to double and single occupancy, respectively. Of note, the
CTCF&BORIS bound regions enclosing one CTCF motif (gene/chromosome
name in red) are showed double occupancy, similar to CTCF&BORIS bound
regions enclosing two CTCF motifs (black), while all CTCF-only bound
regions showed single occupancy. b Three CTCF&BORIS bound regions
(TP53, IRF2BP1 and chr17 intergenic regions), each enclosing two CTCF
motifs, were split into two fragments and subjected to EMSA. The
separation of CTCF motifs resulted in single occupancy of each fragment
with one CTCF motif, confirming the presence of two CTCF binding sites in
each sequence. c 200-bp 32P-labeled probes representing KDM3B, FOXA3,
and TP53 promoters were incubated with nuclear extracts from either K562
or NHDF cells. All lanes contained the indicated nuclear extract, except the
first lane for K562, where only free probe is present (F). Nuclear extracts and
probe were also incubated with either control mouse IgG (−) or antibodies
against CTCF or BORIS. The red and blue arrows point to the super-shift
bands corresponding to CTCF–DNA and BORIS–DNA complexes,
respectively. (PPTX 215 kb)
Additional file 6: Fig. S6. Comparison of DNaseI digital genomic
footprinting (DGF) and phastConss46 conservation score at 2xCTSes and
1xCTSes. a Heatmaps show DNaseI cleavage density mapped in K562 and
NHDF cells at 2xCTSes. 2xCTSes (CTCF&BORIS bound regions in K562 cells)
were sorted into 12 different groups (1000 genomic regions in each group)
depending on the distance between two CTCF motifs. The distance is
shown by double arrows and the number of base pairs between two CTCF
motifs. The same genomic coordinates were used to plot DNaseI cleavage
density mapped in K562 and NHDF cells and for the analysis of average
phastCons46 conservation score (shown in the middle). The schematic
presentation of 2xCTSes with two CTCF motifs (red boxes) under one ChIP-
seq peak and the proposed occupancy of 2xCTSes by CTCF (red circle) and
BORIS (blue circle) in K562 and NHDF cells are shown at the top of panels.
The two CTCF motifs were not sorted based on plus or minus strand. The
tag density data were collected within a 400-bp window around the
first (left) 20-bp CTCF core motifs (0) under a single CTCF ChIP-seq peak.
b Heatmap shows DNaseI cleavage density mapped in K562 cells at
1xCTSes with CTCF motif on minus (upper panel) and plus (lower panel)
strands. The average phastCons conservation score at the same regions
as in DNAseI panels is shown below. c, d Heatmaps show DNaseI cleavage
density mapped in K562 cells at 2xCTSes. 2xCTSes were separated into two
groups with both CTCF motifs located on the plus strand (c) or minus
strand (d). The distance between two CTCF motifs varies from 10 (bottom)
to 100 bp (top). (PPTX 1337 kb)
Additional file 7: Fig. S7. Epigenetic profile of two classes of CTCF
binding regions in BORIS-positive cells (K562). a Heatmaps demonstrate
the association of CTCF&BORIS bound regions with active promoters
(H3K4me3 and RNAPII, ENCODE) and enhancers (H3K27ac, ENCODE)
mapped in K562 cells. The tag density was subjected to k-means ranked
clustering with five clusters expected. b Genome browser view of two
examples of Super Enhancers mapped in K562 cells. H3K27ac and p300
tracks were adopted from ENCODE. c Scatter plots show the overlapping
of CTCF-only and CTCF&BORIS bound regions (left panel) and BORIS-only
and CTCF&BORIS bound regions (right panel) with ChIP-seq data available
for K562 cells by ENCODE. The dots represent the percentage of CTCF-only,
BORIS-only (x-axis), and CTCF&BORIS (y-axis) bound regions overlapping with
each factor mapped by ChIP-seq in K562 cells. The red dots are labeled with
the name of the factor mapped by ChIP-seq. d The percentage of BORIS-
only, CTCF&BORIS and CTCF-only bound regions (y-axis) overlapping with
each factor (x-axis). e Heatmap demonstrates the enrichment of RNAPII,
CAGEs, H3K4me3, H2AZ, H3K27ac, ZNF143, and SMC3 ChIP-seq data
(ENCODE data) at CTCF&BORIS bound regions in contrast to CTCF-only
bound regions. The tag density of ChIP-seq data was collected within a
10-kb window around the summit of CTCF peaks mapped in K562 cells.
The collected data were subjected to k-means clustering using linear
normalization. f Average tag density (tags/10 million) of multiple factors
mapped by ChIP-seq in K562 cells (ENCODE data) across BORIS-only
(blue), CTCF-only (red) and CTCF&BORIS (purple) bound regions mapped
in K562 cells. The names of factors used in ChIP-seq are labeled on the
top of the each plot. g Histogram shows the genomic distribution of
CTCF and BORIS occupancy at promoters plus the 5’ UTR (3 kb up- and
downstream of TSSs), gene bodies, and intergenic regions. (PPTX 680 kb)
Additional file 8: Fig. S8. Epigenetic profile of two classes of CTCF
binding regions in BORIS-negative cells (GM12878). a Average tag density
(tags/10 million) of CTCF, RNAPII, DNaseI digestion, H3K4me3, H3K27ac,
and RAD21 (mapped by ChIP-seq in GM12878 cells, ENCODE data) at
2xCTSes (blue) and 1xCTSes (red). The data were normalized to the
number of mapped reads and binding regions. b Upper panel: scatter
plot shows overlapping of 2xCTSes (y-axis) and 1xCTSes (x-axis) with
multiple ENCODE data available for GM12878. Similar to CTCF&BORIS and
CTCF-only bound regions in K562 (Fig. S7c, left panel in Additional file 7),
no correlation (R2 = 0.41) was found between 2xCTSes and 1xCTSes with
respect to co-occupancy with the majority of transcription factors, histone
modifications, and chromatin remodeling factors. Middle panel: scatter plot
shows an overlapping of 1xCTSes mapped in K562 (y-axis) and in GM12878
cells (x-axis) with ENCODE data for K562 and GM12878 cells, respectively.
1xCTSes of GM12878 and K562 cells were correlated with each other
(R2 = 0.98) with respect to co-occupancy with the majority of ENCODE
data common for the two cell lines. Lower panel: scatter plot shows the
overlapping of 2xCTSes in K562 (y-axis) and in GM12878 (x-axis) with ENCODE
data for K562 and GM12878 cells (R2 = 0.93), respectively. (PPTX 220 kb)
Additional file 9: Fig. S9. BORIS occupancy in cancer cells recapitulates
the BORIS occupancy in germ cells. a Average tag density of CTCF (red)
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and BORIS (blue) occupancies mapped in OVCAR8 and Delta47 cells
across the conserved mouse binding regions (upper panel). b Gene tracks
representing the examples of conserved BORIS-only, CTCF-only and
CTCF&BORIS bound regions in germline (round spermatids) and cancer
cells (K562). (PPTX 104 kb)
Additional file 10: Fig. S10. BORIS is involved in transcriptional
program of cancers. a The sequence recognized by ZFN and cleaved by
Fok I is shown by black and red letters, respectively. b Surveyor assay (CEL-I)
for ZFN-induced mutations in the BORIS gene. The proportions of wild-type
and mutant alleles are shown as a table at the bottom of the gel. c Surveyor
assay shows ten single-cell clones with the mutated BORIS locus. d Western
blot shows the level of BORIS protein in wild type (wt) and ten mutant
clones from panel (c). e K562 cells transfected with ZFN produced at least
ten times less colonies in soft agar compared with control. f Western
blot shows the level of BORIS protein in K562 before (0) and after
phorbol 12-myristate 13-acetate (PMA) treatment. Wright–Giemsa
staining analysis of K562 transfected with either control vector or ZFN
in comparison with K562 treated with PMA for 3 days. Both transfection
of K562 with ZFN and treatment with PMA showed morphologic
changes related to megakaryocytic differentiation. h Upper panel: ChIP-seq
and RNA-seq tracks show CTCF and BORIS occupancy at the WISP2 gene
and dowregulation of WISP2 expression upon BORIS induction in MCF7 cells.
Lower panel: RNA-seq RPKM values for the WISP2 gene expression. i
Downregulation of inflammatory response pathway in response to
stable BORIS expression in MCF7 cells. k ChIP-seq tracks show CTCF
and BORIS occupancy at GAL3ST1, FOXA3, and PRAME loci in NHDF,
OVCAR8, Delta47, and K562 cells. The tracks are labeled with the
molecules against which antibodies were directed and cell lines used
in ChIP-seq. RNA-Seq tracks demonstrate gene expression in BORIS-positive
cells (K562) in contrast to BORIS-negative cells (NHEK and NHDF). l
Quantitative PCR analysis of GAL3ST1, FOXA3, and PRAME gene expression in
BORIS-positive cells (Testes, K562, OVCAR8, Delta47) and BORIS-negative cells
(GM12878, NHDF, NHEK). (PPTX 1328 kb)
Additional file 11: Table S1. Pathways altered with BORIS
downregulation in K562 cells. Table S2 Functional annotation of genes
that changed transcription upon BORIS downregulation in K562 cells.
Table S3 The top diseases and functions enriched for the genes that
changed transcription upon BORIS downregulation in K562 cells. Table
S4 Pathways altered with BORIS induction in MCF7 cells. Table S5
Functional annotation of genes that changed transcription upon BORIS
induction in MCF7 cells (Clone1). Table S6 The top diseases and
functions enriched for the genes that changed transcription upon BORIS
induction in MCF7 cells (Clone1). Table S7 Comparison of functional
annotation of genes that changed transcription upon BORIS depletion
(K562) and BORIS induction (MCF7, Clone1). Table S8 Comparison of
canonical pathways that altered upon BORIS depletion (K562) and BORIS
induction (MCF7, Clone1). (XLSX 257 kb)
Additional file 12: Fig. S11. CTCF and BORIS bound regions enriched at
the anchors of cell-type specific transcriptional loops in K562 cells compared
with MCF7 cells. a Heatmap shows the enrichment of BORIS, CTCF, and RNAPII
occupancy in K562 cells at the left and right anchors of K562-specific
loops. b Heatmap shows the enrichment of CTCF and RNAPII occupancy
in MCF7 cells at the anchors of K562-specific loops, but the interactions
mediated by CTCF were different in MCF7 cells compared with K562 cells.
c Genomic view of K562-specific long-range chromatin interactions at
the COMMD7-DNMT3B-MAPRE1 locus. The tracks are labeled with the
molecules against which antibodies were directed in ChIP-seq in both
K562 and MCF7 cells. ChIA-PET data are presented as red lines with bold
anchors and summarized by brackets on the top of the gene tracks. d Model
of cluster and single CTCF binding classes and their modulation by BORIS in
BORIS-positive cells. The model is based on ChIP-seq and ChIA-PET data for
K562 and MCF7 cells at the DNMT3B locus (c), but also observed in TP53,
FOXA3, PRAME, KDM3B, MDM2, BBC3 and other loci. (PPTX 209 kb)
Additional file 13: Table S9 The primers used in the study for
amplification of EMSA probes and for quantitative PCR. (DOCX 17 kb)
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